DiPeri TP, Zhao M, Evans KW, Varadarajan K, et al. Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma. J Hepatol 2023 Nov 14:S0168-8278(23)05274-1. doi: 10.1016/j.jhep.2023.
PMID: 37972659